Cargando…

Effect of increasing intravenous glucose load in the presence of normoglycemia on outcome and metabolism in critically ill rabbits

Detalles Bibliográficos
Autores principales:	Derde, S, Vanhorebeek, I, Ververs, E, Darras, V, Van Herck, E, Berghe, G Van den
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084005/ http://dx.doi.org/10.1186/cc7283

Ejemplares similares

Organ dysfunction in critical illness: impact of maintaining normoglycemia and glycemia-independent insulin actions
por: Ellger, B, et al.
Publicado: (2006)

Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness
por: Mebis, Liese, et al.
Publicado: (2009)

Insufficient autophagy relates to mitochondrial dysfunction, organ failure and adverse outcome in an animal model of critical illness
por: Gunst, J, et al.
Publicado: (2012)

Intensive insulin therapy to maintain normoglycemia after cardiac surgery
por: Van den Berghe, G
Publicado: (2011)

The Role of Autophagy in Critical Illness-induced Liver Damage
por: Thiessen, Steven E., et al.
Publicado: (2017)

Effects of Intravenous Glucose Load on Insulin Secretion in Patients With Ketosis-Prone Diabetes During Near-Normoglycemia Remission
por: Gosmanov, Aidar R., et al.
Publicado: (2010)

Protection of mitochondria by intensive insulin therapy in critical illness: blood glucose control or insulin?
por: Vanhorebeek, I, et al.
Publicado: (2006)

Strict blood glucose control with insulin improves hepatic mitochondrial ultrastructure and function in critical illness
por: Vanhorebeek, I, et al.
Publicado: (2004)

Early Supplemental Parenteral Nutrition in Critically Ill Children: An Update
por: Jacobs, An, et al.
Publicado: (2019)

Fibroblast growth factor 21 response to critical illness: effect of blood glucose control and relation with mitochondrial dysfunction, the integrated stress response and survival
por: Thiessen, S, et al.
Publicado: (2015)

Skeletal Muscle Myokine Expression in Critical Illness, Association With Outcome and Impact of Therapeutic Interventions
por: Vanhorebeek, Ilse, et al.
Publicado: (2023)

Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe?
por: Berghe, Greet Van den
Publicado: (2010)

Impact of early versus late parenteral nutrition on morphological and molecular markers of atrophy and autophagy in skeletal muscle of critically ill patients
por: Vanhorebeek, I, et al.
Publicado: (2013)

Intensive insulin therapy in critically ill children: impact on blood glucose dynamics and its relation with mortality
por: Van Tornout, M, et al.
Publicado: (2013)

Expression of glucose transporters in critical illness
por: Langouche, L, et al.
Publicado: (2006)

Receptor for advanced glycation end products axis in critically ill patients
por: Ingels, C, et al.
Publicado: (2014)

Insufficient activation of autophagy allows accumulation of cellular damage and may contribute to sustained organ failure in prolonged critically ill patients
por: Gunst, J, et al.
Publicado: (2011)

Premorbid obesity, but not nutrition, prevents critical illness‐induced muscle wasting and weakness
por: Goossens, Chloë, et al.
Publicado: (2016)

Cortisol metabolism in critical illness: effects of intensive insulin therapy
por: Vanhorebeek, I, et al.
Publicado: (2005)

Regulation of type 1 deiodinase activity in prolonged critical illness
por: Debaveye, Y, et al.
Publicado: (2006)

Development of muscle weakness in a mouse model of critical illness: does fibroblast growth factor 21 play a role?
por: Vankrunkelsven, Wouter, et al.
Publicado: (2023)

Reduced cortisol metabolism drives hypercortisolism in critical illness
por: Boonen, E, et al.
Publicado: (2012)

Ingredients for adequate evaluation of blood glucose algorithms as applied to the critically ill
por: Van Herpe, Tom, et al.
Publicado: (2009)

Persisting neuroendocrine abnormalities and their association with physical impairment 5 years after critical illness
por: Vanhorebeek, Ilse, et al.
Publicado: (2021)

Intensive insulin therapy and brief hypoglycemia do not increase neurological injury markers in critically ill children
por: Gielen, M, et al.
Publicado: (2010)

DNA methylation alterations in muscle of critically ill patients
por: Van Dyck, Lisa, et al.
Publicado: (2022)

Health-related quality of life of children and their parents 6 months after children’s critical illness
por: Hordijk, José, et al.
Publicado: (2019)

Neurocognitive consequences of iatrogenicphthalate exposure during critical illness in children: a study of a development and validation cohort
por: Verstraete, S, et al.
Publicado: (2015)

On the Role of Illness Duration and Nutrient Restriction in Cholestatic Alterations that Occur During Critical Illness
por: Jenniskens, Marc, et al.
Publicado: (2018)

The association of hypoglycemia with outcome of critically ill children in relation to nutritional and blood glucose control strategies
por: Gunst, Jan, et al.
Publicado: (2023)

OR17-1 Changes in the Hypothalamic-Pituitary-Adrenal Axis during Pediatric Critical Illness
por: Jacobs, An, et al.
Publicado: (2019)

Mechanisms of kidney protection by intensive insulin therapy during critical illness
por: Vanhorebeek, I, et al.
Publicado: (2008)

Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages
por: Marques, M, et al.
Publicado: (2013)

SAT-155 Temporal Activation of the Unfolded Protein Response and Concomitant Downregulation of Key Hepatic Transcription Factors in Critical Illness
por: Vankrunkelsven, Wouter, et al.
Publicado: (2019)

Critical illness induces alternative activation of M2 macrophages in adipose tissue
por: Langouche, Lies, et al.
Publicado: (2011)

SUN-548 Ketone Bodies in Critical Illness Alter Cholesterol Synthesis in Skeletal Muscle, Interlinked with Protection Against Weakness
por: Goossens, Chloë, et al.
Publicado: (2020)

Efficacy and safety of ketone ester infusion to prevent muscle weakness in a mouse model of sepsis-induced critical illness
por: Weckx, Ruben, et al.
Publicado: (2022)

Effect of restoration of 25OHD(3 )status in prolonged critical illness on serum innate immunity parameters LL-37 and sCD163
por: Ingels, CM, et al.
Publicado: (2010)

Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
por: Goossens, Chloë, et al.
Publicado: (2021)

Effects of hyperglycemia and intensive insulin therapy on neurons and glial cells during critical illness
por: Sonneville, R, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m8hjkjhbmsqamak6g29fce2kfv